Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA)

About the company

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

254

CEO

Amy M. Trombly

Exchange

NASDAQ

Website

http://www.sonomapharma.com

$19.00M

Total Revenue

254

Employees

$6.46M

Market Capitalization

-2.07

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$9M

Operating Margin (in %)

Total operating margin

$-7M

Net Margin (in %)

Total net margin

$-5M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11600.40 1376.00 4.95 18.29 43.06
Catalent, Inc. CTLT 10838.26 2872.00 5.44 103.91 3.63
Perrigo Co. Plc PRGO 7571.99 4837.00 1.30 51.65 3.02
Bausch Health Cos., Inc. BHC 6707.00 8597.00 9.36 -3.54 -21.96
Jazz Pharmaceuticals Plc JAZZ 6338.40 2188.00 2.19 23.17 12.81
United Therapeutics Corp. UTHR 5118.72 1443.00 1.78 9.88 36.59
MyoKardia, Inc. MYOK 4243.04 34.00 12.33 -13.69 -201.73
Axsome Therapeutics, Inc. AXSM 2833.95 None 19.23 -31.51 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Pacira Biosciences, Inc. PCRX 2199.54 435.00 5.90 -5237.00 -0.02
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2039.84 335.00 4.68 19.22 31.64
Prestige Consumer Healthcare, Inc. PBH 1850.28 963.00 1.56 13.05 14.77
Revolution Medicines, Inc. RVMD 1738.14 48.00 4.51 -24.55 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1673.70 0.00 4.47 -16.38 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1598.26 440.00 -22.62 18.85 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1475.20 272.00 -43.90 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1313.55 5.00 3.59 -3.09 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Theravance Biopharma, Inc. TBPH 1169.64 88.00 -8.21 -4.74 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1074.08 327.00 2.68 21.08 15.90
Endo International Plc ENDP 824.22 3014.00 -1.13 -2.94 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Assembly Biosciences, Inc. ASMB 676.86 16.00 3.04 -6.80 -601.75
Eagle Pharmaceuticals, Inc. EGRX 671.16 192.00 3.61 266.33 1.29
Aerie Pharmaceuticals, Inc. AERI 641.70 79.00 5.09 -3.17 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Anika Therapeutics, Inc. ANIK 533.82 125.00 1.84 19.26 22.73
Catalyst Pharmaceuticals, Inc. CPRX 524.30 119.00 5.10 11.95 36.09
Intersect ENT, Inc. XENT 439.36 102.00 4.15 -8.80 -48.61
BioDelivery Sciences International, Inc. BDSI 408.48 130.00 5.84 -55.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 370.68 203.00 1.90 -237.62 -0.67
Albireo Pharma, Inc. ALBO 337.35 11.00 3.43 -4.41 -730.55
MEI Pharma, Inc. MEIP 283.86 5.00 4.89 -7.28 -539.48
Mallinckrodt Plc MNK 209.16 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 163.43 None 2.66 -7.91 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 95.82 1.00 67.01 -5.15 None
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Zynerba Pharmaceuticals, Inc. ZYNE 80.50 0.00 1.32 -2.24 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
CTI BioPharma Corp. CTIC 69.62 3.00 3.11 -1.69 -111.83
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 63.90 3.00 5.14 -5.00 -464.15
Cassava Sciences, Inc. SAVA 56.43 41.00 2.97 -12.38 76.71
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Natural Alternatives International, Inc. NAII 48.58 114.00 0.67 -12.85 -3.19
Lipocine, Inc. LPCN 43.50 0.00 10.36 -2.90 None
IsoRay, Inc. ISR 37.52 9.00 7.00 -11.20 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.45 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.18 0.00 -2.60 -2.88 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.24 3.00 2.39 -1.62 -264.21
Regulus Therapeutics, Inc. RGLS 14.49 0.00 1.28 -0.68 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.43 None 1.34 -0.24 None
VIVUS, Inc. VVUS 8.69 73.00 -0.19 -0.29 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.46 19.00 1.02 -2.07 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.68 None 1.77 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.20 None 1.05 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Passes Above Two Hundred Day Moving Average of $5.45

1d ago, source: modernreaders.com

Sonoma Pharmaceuticals Inc (NASDAQ:SNOA)’s share price crossed above its 200-day moving average during trading on Friday .

Sonoma Pharmaceuticals Inc.

27d ago, source: MarketWatch

02/14/2019 N/A SC 13G/A Institutional Ownership * 03/09/2018 N/A SC 13G Institutional Ownership 02/13/2018 N/A SC 13G Institutional Ownership 02/05/2016 N/A SC 13G/A Institutional Ownership * 01 ...

Sonoma Pharmaceuticals Announces Expanded Distribution Agreement with Brill International S.L. for Europe and approval of new CE Marking for Microdacyn

1mon ago, source: Business Wire

PETALUMA, Calif.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of ...

Sonoma Pharmaceuticals stock nearly triples after disinfectant allowed to carry COVID-19 label in Australia

1mon ago, source: MSN

Shares of Sonoma Pharmaceuticals Inc. (snoa) nearly tripled on heavy volume in premarket trading Friday, after the California-based producer of hypochlorous acid products and partner Dubai-based ...

BRIEF-Sonoma Pharmaceuticals Entered Into Agreement With Brill International

1mon ago, source: Reuters

May 26 (Reuters) - Sonoma Pharmaceuticals Inc: * SONOMA PHARMACEUTICALS - ON MAY 19 ENTERED INTO A NEW LICENSE AND DISTRIBUTION AGREEMENT WITH EXISTING PARTNER BRILL INTERNATIONAL S.L. * SONOMA ...

BRIEF-Sonoma Pharmaceuticals Receives COVID-19 label claim approval for Nanocyn disinfectant in Australia

1mon ago, source: Reuters

May 28 (Reuters) - Sonoma Pharmaceuticals Inc: * SONOMA PHARMACEUTICALS AND MICROSAFE GROUP ANNOUNCE THAT NANOCYN® DISINFECTANT & SANITIZER HAS RECEIVED APPROVAL TO BE ENTERED INTO THE AUSTRALIAN ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.